Breast cancer patients can stop tamoxifen after 5 years.
作者信息
Gottlieb S
出版信息
West J Med. 2001 Jul;175(1):13. doi: 10.1136/ewjm.175.1.13.
Abstract
摘要
相似文献
1
Breast cancer patients can stop tamoxifen after 5 years.
West J Med. 2001 Jul;175(1):13. doi: 10.1136/ewjm.175.1.13.
2
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71567-1.
3
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71566-X.
4
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):66-7. doi: 10.1016/S0140-6736(05)71563-4.
5
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):65-6; author reply 67. doi: 10.1016/S0140-6736(05)71562-2.
6
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(00)03579-0.
7
Tamoxifen and risk of endometrial cancer.
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(05)71561-0.
8
Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
Obstet Gynecol. 2005 Jan;105(1):217-8; author reply 218-9. doi: 10.1097/01.AOG.0000148262.25836.38.
9
Tamoxifen in the treatment of breast cancer in the older woman.
Age Ageing. 1999 Oct;28(6):583-4. doi: 10.1093/ageing/28.6.583.
10
Long-term tamoxifen trial halted.
Science. 1995 Dec 8;270(5242):1562.
本文引用的文献
1
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.
J Natl Cancer Inst. 2001 May 2;93(9):684-90. doi: 10.1093/jnci/93.9.684.
2
Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.
Ann Intern Med. 1987 May;106(5):649-54. doi: 10.7326/0003-4819-106-5-649.
Zotero 插件